Stay informed with the latest litigation news. Explore now

IP Verse

Merck Serono competitive analysis

Latest publications and patents of Merck Serono New

Explore the latest publications and patents granted to Merck Serono, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Merck Serono

EP4070800
Oct 16, 2024Cladribine Regimen For Treating Multiple SclerosisGranted And Under Opposition
EP2805723
Jan 17, 2018Cladribine Regimen For Treating Multiple SclerosisRevoked
EP2164877
Dec 13, 2017The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein ProductionRevoked

Latest oppositions filed by Merck Serono

Explore patent oppositions filed by Merck Serono against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2292252
Unitary Combination Of Fsh And HcgFERRINGMay 5, 2020
EP3045471
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGDec 22, 2017

Latest patents of Merck Serono opposed by its competitors

Explore Merck Serono's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4070800
Oct 16, 2024Cladribine Regimen For Treating Multiple Sclerosis1
EP2805723
Jan 17, 2018Cladribine Regimen For Treating Multiple Sclerosis1
EP2164877
Dec 13, 2017The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production1

Latest PTAB cases involving Merck Serono New

Discover the latest PTAB cases involving Merck Serono, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 12, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Merck Serono

IPR2023-00481Jan 23, 2023HOPEWELL PHARMA VENTURESMERCK SERONOFinal Written Decision - Appealed
IPR2023-00480Jan 23, 2023HOPEWELL PHARMA VENTURESMERCK SERONOFinal Written Decision - Appealed
IPR2023-00050Oct 14, 2022TWI PHARMACEUTICALSMERCK SERONOFinal Written Decision - Appealed
IPR2023-00049Oct 14, 2022TWI PHARMACEUTICALSMERCK SERONOFinal Written Decision - Appealed

Top competitors of Merck Serono

Top competitors of Merck Serono based on patent oppositions.